GENE ONLINE|News &
Opinion
Blog

University of Oxford
Special Cancer
Anti-cancer Agent Derived From Himalayan Caterpillar Fungus Shines in Early Trials
2021-10-14
Technology COVID-19
Oxford, Prenetics Join Forces To Scale Award-Winning Rapid Molecular Testing Technology
2021-04-26
COVID-19 Pandemic
COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic
2021-01-08
COVID-19
AstraZeneca, Bharat Biotech Vaccines Nab Emergency Approval in India
2021-01-04
COVID-19 Vaccine
COVID-19: Oxford/AstraZeneca’s DNA Vaccine Scores Emergency Use Approval in the UK
2020-12-30
COVID-19 Vaccine
Spotlight: Comprehensive Analysis of Late-Stage Trial Data of AstraZeneca’s COVID-19 Vaccine
2020-12-10
COVID-19 Vaccine
Cheaper and Fridge-Stable AstraZeneca Vaccine is 90% Effective in Preventing COVID-19
2020-11-23
COVID-19 Vaccine
Oxford-AstraZeneca’s COVID-19 Vaccine Demonstrates Strong Immune Response in the Elderly
2020-11-20
Weekly Asia Highlights- China and Japan
2020-08-06
COVID-19
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19 Dexamethasone
Dexamethasone Renews Hopes for a Life Saving COVID-19 Treatment
2020-06-20
COVID-19 Vaccine
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top